Tradestie Institutional Equity Comparison Engine

SLSN vs NPCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLSN Overall Edge

SLSN Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solesence, Inc. Common Stock (SLSN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SLSN trades at 11.4x Forward P/E with 4.5% operating margin (+38.1% YoY revenue) versus NPCT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SLSN sits in CONSOLIDATION (N/A IV; Dealer Gamma Walls on Pro) against NPCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SLSN
SLSN 11.4x vs NPCT N/M Fwd P/E
Growth & Margin Winner SLSN
Op Margin 4.5% vs N/A ยท YoY +38.1% vs N/A
Momentum & Technical Winner SLSN
1Y -28.1% vs -16.4% ยท 52W Pos 47% vs 3%
Options & Structure Winner SLSN
CONSOLIDATION (N/A IV) vs UNCLASSIFIED (N/A IV)
SLSN NASDAQ
Solesence, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$1.41
-4.73% 1D
Market Cap $104.6M
1M Return +64.62%
1Y Return -28.06%
Forward P/E 11.4x
Unified AI Score
32.4 / 100 SELL
Tech 50.0 Fund 32.0 Flow 50.0 Mom 40.0
NPCT NYSE
Nuveen Core Plus Impact Fund
Institutional Equity
$8.68
-0.34% 1D
Market Cap $315.2M
1M Return -2.8%
1Y Return -16.38%
Forward P/E N/M
Unified AI Score
32.9 / 100 SELL
Tech 2.0 Fund 41.0 Flow 50.0 Mom 65.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SLSN -28.06% NPCT -16.38% Spread: +11.68 pp (NPCT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SLSN TTM Op. Margin: 4.5% NPCT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SLSN vs NPCT. Trailing 12-month operating profitability (SLSN 4.5% vs NPCT N/A) and valuation multiples (SLSN 11.4x vs NPCT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SLSN (7) vs NPCT (3)
Institutional Metric SLSN NPCT Criterion Row Winner
Market Capitalization Scale $104.6M $315.2M Larger Scale NPCT
Trailing P/E Ratio Valuation 49.3x N/M Lower Multiple SLSN
Forward P/E Ratio Valuation 11.4x N/M Lower Multiple SLSN
Revenue Growth (YoY) Growth +38.1% N/A Higher Growth SLSN
Operating Margin (TTM) Profitability 4.5% N/A Higher Margin SLSN
Net Profit Margin Profitability 3.0% N/A Higher Margin SLSN
Return on Equity (ROE) Capital Efficiency 10.7% N/A Higher ROE SLSN
52-Week Range Position Momentum 47% ($1โ€“$2) 3% ($9โ€“$11) Stronger Trend SLSN
Beta / 30D Volatility Risk Regime 1.49ฮฒ ยท 238% Vol 0.36ฮฒ ยท 13% Vol Lower Realized Risk NPCT
Unified Institutional Score Composite Signal 32.4 / 100 (SELL) 32.9 / 100 (SELL) Higher Composite NPCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SLSN vs NPCT Buy Guide
SLSN CONSOLIDATION
130d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SLSN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NPCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NPCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SLSN nor NPCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.